Catalyst Biosciences (CBIO) Competitors

OPKO Health (NASDAQ:OPK) and Catalyst Biosciences (NASDAQ:CBIO) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, media sentiment, risk, institutional ownership, valuation, dividends, earnings, community ranking and analyst recommendations.

Is OPK or CBIO more profitable?

Catalyst Biosciences has a net margin of 0.00% compared to OPKO Health's net margin of -18.65%. OPKO Health's return on equity of -9.76% beat Catalyst Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OPKO Health	-18.65%	-9.76%	-6.46%
Catalyst Biosciences	N/A	-364.68%	-281.68%

Do insiders and institutionals have more ownership in OPK or CBIO?

64.6% of OPKO Health shares are held by institutional investors. Comparatively, 6.0% of Catalyst Biosciences shares are held by institutional investors. 49.7% of OPKO Health shares are held by insiders. Comparatively, 2.9% of Catalyst Biosciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Do analysts rate OPK or CBIO?

OPKO Health currently has a consensus target price of $2.75, suggesting a potential upside of 106.77%. Given OPKO Health's stronger consensus rating and higher probable upside, research analysts plainly believe OPKO Health is more favorable than Catalyst Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OPKO Health	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75
Catalyst Biosciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Does the media refer more to OPK or CBIO?

In the previous week, Catalyst Biosciences had 5 more articles in the media than OPKO Health. MarketBeat recorded 8 mentions for Catalyst Biosciences and 3 mentions for OPKO Health. OPKO Health's average media sentiment score of 0.76 beat Catalyst Biosciences' score of 0.00 indicating that OPKO Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OPKO Health	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Catalyst Biosciences	0 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has better earnings and valuation, OPK or CBIO?

Catalyst Biosciences has lower revenue, but higher earnings than OPKO Health. OPKO Health is trading at a lower price-to-earnings ratio than Catalyst Biosciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OPKO Health	$689.41M	1.53	-$188.86M	-$0.07	-19.00
Catalyst Biosciences	$790K	7.55	-$8.24M	-$1.38	-0.11

Which has more risk & volatility, OPK or CBIO?

OPKO Health has a beta of 1.39, meaning that its stock price is 39% more volatile than the S&P 500. Comparatively, Catalyst Biosciences has a beta of 1.05, meaning that its stock price is 5% more volatile than the S&P 500.

Does the MarketBeat Community prefer OPK or CBIO?

OPKO Health received 205 more outperform votes than Catalyst Biosciences when rated by MarketBeat users. However, 68.29% of users gave Catalyst Biosciences an outperform vote while only 65.60% of users gave OPKO Health an outperform vote.

Company	Underperform	Outperform
OPKO Health	Outperform Votes 513 65.60%	Underperform Votes 269 34.40%
Catalyst Biosciences	Outperform Votes 308 68.29%	Underperform Votes 143 31.71%

Summary

OPKO Health beats Catalyst Biosciences on 12 of the 18 factors compared between the two stocks.